Tulane University Health Sciences Center

CLIA Laboratory Citation Details

3
Total Citations
29
Total Deficiencyies
13
Unique D-Tags
CMS Certification Number 19D0994686
Address 1430 Tulane Avenue, 86-79, Room 6524, New Orleans, LA, 701122632
City New Orleans
State LA
Zip Code701122632
Phone(504) 988-5263

Citation History (3 surveys)

Survey - June 10, 2025

Survey Type: Standard

Survey Event ID: 7PAA11

Deficiency Tags: D0000 D2014 D5415 D6087 D6089 D0000 D2014 D5415 D6087 D6089

Summary:

Summary Statement of Deficiencies D0000 A Recertification survey was performed at Tulane University Health Sciences Center, CLIA ID 19D0994686, on June 10, 2025. The laboratory was found in compliance with 42 CFR 493 Requirements for Laboratories; however, standard level deficiencies were cited. D2014 TESTING OF PROFICIENCY TESTING SAMPLES (b)(6) The laboratory must document the handling, preparation, processing, examination, and each step in the testing and reporting of results for all proficiency testing samples. The laboratory must maintain a copy of all records, including a copy of the proficiency testing program report forms used by the laboratory to record proficiency testing results including the attestation statement provided by the PT program, signed by the analyst and the laboratory director, documenting that proficiency testing samples were tested in the same manner as patient specimens, for a minimum of two years from the date of the proficiency testing event. This STANDARD is not met as evidenced by: Based on review of the laboratory's proficiency testing records and interview with personnel, the laboratory failed to ensure the proficiency testing attestation statements for Immunohistochemistry were signed by testing personnel and/or the Laboratory Director for two (2) of three (3) events reviewed. Findings: 1. Review of the laboratory's proficiency testing records revealed the laboratory enrolled in the College of American Pathologists (CAP ) proficiency testing (PT) program to verify the accuracy of Immunohistochemistry testing. 2. Review of the 2024 and 2025 CAP Immunohistochemistry PT records revealed the following documentation was not completed: 2024: MK-A event for Immunohistochemistry, the Laboratory Director did not sign the attestation statement 2025: MK-A event for Immnnohistochemistry, Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- the Laboratory Director and Testing Personnel did not sign the attestation statement 3. In interview on June 10, 2025 at 12:56 pm, the General Supervisor confirmed the identified PT events did not have signed attestation statement forms. D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) (c) Reagents, solutions, culture media, control materials, calibration materials, and other supplies, as appropriate, must be labeled to indicate the following: (c)(1) Identity and when significant, titer, strength or concentration. (c)(2) Storage requirements. (c)(3) Preparation and expiration dates. (c)(4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: Based on observation by surveyor and interview with personnel, the laboratory failed to label reagents in secondary containers with the correct expiration date. Findings: 1. Observation by surveyor during the laboratory tour on June 10, 2025 at 9:38 am revealed the following reagents in secondary bottles: a) 3% Acetic Acid " Prep date 5 /15/23 Exp date 8/15/23" with the following note on bottle "Never use expired reagent." b) 95% Ethanol: "Prep date 6-9-25 Exp 5-31-20, lot 227850" 2. In interview on June 10, 2025 at 10:20 am, the General Supervisor stated the 3% Acetic Acid is made by personnel weekly. The General Supervisor stated the bottle is not updated with the current preparation and expiration dates. 3. In interview on June 10, 2025 at 10:20 am, Personnel 1 stated she prepared the identified 95% Ethanol on June 9, 2025 as listed and not put the correct expiration date on the secondary bottle. D6087 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(3)(iii) (e)(3)(iii) Laboratory personnel are performing the test methods as required for accurate and reliable results; This STANDARD is not met as evidenced by: Based on observation by surveyor and interview with personnel, the Laboratory Director failed to ensure the laboratory personnel performed test methods as required. Refer to D5415. D6089 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(4)(i) (e)(4)(i) The proficiency testing samples are tested as required under subpart H of this part; This STANDARD is not met as evidenced by: Based on review of the laboratory's proficiency testing records and interview with personnel, the laboratory failed to maintain the attestation statements for two (2) of three (3) testing events reviewed. Refer to D2014. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - May 31, 2023

Survey Type: Standard

Survey Event ID: 6GVC11

Deficiency Tags: D0000 D5785 D6096 D6103 D6126 D0000 D5785 D6096 D6103 D6126

Summary:

Summary Statement of Deficiencies D0000 A Certification survey was performed on May 31, 2023 at Tulane University Health Sciences Center, CLIA ID # 19D0994686. The laboratory was found in compliance with 42 CFR 493 Requirements for Laboratories; however, standard level deficiencies were cited. D5785

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - March 14, 2019

Survey Type: Standard

Survey Event ID: A8OK11

Deficiency Tags: D5793 D6093 D6094 D6093 D6094 D5601 D0000 D5601 D5793

Summary:

Summary Statement of Deficiencies D0000 A Certification Survey was performed on March 14, 2019 at Tulane University Health Sciences Center, CLIA ID # 19D0994686. The laboratory was found in compliance with 42 CFR 493 Requirements for Laboratories; however, standard level deficiencies were cited. D5601 HISTOPATHOLOGY CFR(s): 493.1273(a)(f) (a) As specified in 493.1256(e)(3), fluorescent and immunohistochemical stains must be checked for positive and negative reactivity each time of use. For all other differential or special stains, a control slide of known reactivity must be stained with each patient slide or group of patient slides. Reactions of the control slide with each special stain must be documented. (f) The laboratory must document all control procedures performed, as specified in this section. This STANDARD is not met as evidenced by: I. Based on record review and interview with personnel, the laboratory failed to document the performance of a control slide for Hematoxylin and Eosin (H&E) staining for five (5) of eighty seven (87) days reviewed. Findings: 1. Review of the laboratory's "Quality Control" policy and procedure revealed "Daily QC will be performed on all stains using the Special Stain/IHC Control Slide Reactivity Form to ensure that the staining process was performed successfully and that the lab is obtaining the correct results." 2. Review of the laboratory's H&E quality control records for May 2018 through August 2018 revealed the laboratory did not document the staining acceptability for the following five (5) days: May 4, 2018: total of 133 slides processed May 18, 2018: total of 173 slides processed May 25, 2018: total of 130 slides processed July 12, 2018: total of 273 slides processed August 30, 2018: total of 180 slides processed 3. In interview on March 14, 2019 at 11:35 am, Personnel 2 stated the evaluating pathologist did not document the H&E stain quality Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- on the laboratory's quality control form for the identified dates. II. Based on record review and interview with personnel, the laboratory failed to document the performance of a control slide with known reactivity for Special stains for three (3) of twelve (12) patients reviewed. Findings: 1. Review of the laboratory's "Quality Control" policy and procedure revealed "Daily QC will be performed on all stains using the Special Stain/IHC Control Slide Reactivity Form to ensure that the staining process was performed successfully and that the lab is obtaining the correct results." 2. Review of random selection of patients and quality control records revealed the laboratory did not document the performance of quality control for the following patients: May 24, 2018: Patient 1: AFB and Fite May 25, 2018: Patient 2: Phh3 February 22, 2019: Patient 3: CD31 3. In interview on March 14, 2019 at 11:59 am, Personnel 2 stated the laboratory did not document the quality control for the identified patients. D5793 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(b)(c) (b) The analytic systems quality assessment must include a review of the effectiveness of

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access